These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3828958)

  • 1. Levamisole as adjuvant immunotherapy in breast cancer.
    Treurniet-Donker AD; Meischke-de Jongh ML; van Putten WL
    Cancer; 1987 May; 59(9):1590-3. PubMed ID: 3828958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer.
    Gröhn P; Heinonen E; Klefström P; Tarkkanen J
    Cancer; 1984 Aug; 54(4):670-4. PubMed ID: 6744203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levamisole in the treatment of stage II breast cancer. Five-year follow-up of a randomized double-blind study.
    Klefström P; Holsti P; Gröhn P; Heinonen E; Holsti L
    Cancer; 1985 Jun; 55(12):2753-7. PubMed ID: 2986823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. II. 5-year results and influence of levamisole.
    Klefström P; Gröhn P; Heinonen E; Holsti L; Holsti P
    Cancer; 1987 Sep; 60(5):936-42. PubMed ID: 3300953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.
    Spitler LE; Sagebiel R
    N Engl J Med; 1980 Nov; 303(20):1143-7. PubMed ID: 6999349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy of poor prognosis colon cancer with levamisole: results of an EORTC double-blind randomized clinical trial.
    Arnaud JP; Buyse M; Nordlinger B; Martin F; Pector JC; Zeitoun P; Adloff A; Duez N
    Br J Surg; 1989 Mar; 76(3):284-9. PubMed ID: 2655812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double blind randomized prospective trial of levamisole/placebo in stage I cutaneous malignant melanoma.
    Loutfi A; Shakr A; Jerry M; Hanley J; Shibata HR
    Clin Invest Med; 1987 Jul; 10(4):325-8. PubMed ID: 3308241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant intermittent chemoimmunotherapy for primary breast cancer: a prospective study with immunologic follow-up.
    Betzler M; Schreml W; Lang M; Lohrmann HP; Flad HD; Schlag P; Herfarth C; Heimpel H
    Recent Results Cancer Res; 1982; 80():185-91. PubMed ID: 7036282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant systemic treatment of resectable breast cancer: eleven years results of a monoinstitutional chemo-hormone-immunotherapy trial.
    Rosso R; Boccardo F; Brema F; Sertoli MR; Amoroso D; Bertelli G; Pronzato P
    Anticancer Res; 1989; 9(4):1153-6. PubMed ID: 2817796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levamisole granulocytopenia in patients receiving an adjuvant chemoimmunotherapy program after surgery for breast carcinoma with axillary lymph node involvement.
    Vogel CL; Lipscomb DL; Silverman MA; Kerns AL; Mansell PW; Sugarbaker EV
    Cancer Treat Rep; 1978 Oct; 62(10):1587-9. PubMed ID: 709561
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemo-immunotherapy with levamisole in metastatic breast carcinoma: a controlled clinical trial.
    Paterson AH; Edwards AM; Nutting M; Schinnour D; Takats L; McClelland A
    Cancer Clin Trials; 1980; 3(1):5-10. PubMed ID: 6993035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival following levamisole or placebo adjuvant treatment of colorectal cancer: a Western Cancer Study Group Trial.
    Chlebowski RT; Nystrom S; Reynolds R; Weiner JM; Bateman JR
    Oncology; 1988; 45(3):141-3. PubMed ID: 3285278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levamisole in Crohn's disease: a randomized, double-blind, placebo-controlled clinical trial.
    Sachar DB; Rubin KP; Gumaste V
    Am J Gastroenterol; 1987 Jun; 82(6):536-9. PubMed ID: 3554991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levamisole in the treatment of advanced breast cancer. A ten-year follow-up of a randomized study.
    Klefström P; Nuortio L
    Acta Oncol; 1991; 30(3):347-52. PubMed ID: 2036245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interim analysis of a double-blind phase-III clinical trial of adjuvant levamisole versus control in resectable Dukes-C colon cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.
    Arnaud JP; Buyse M; Adloff M; Nordlinger B; Pector JC; Duez N
    Recent Results Cancer Res; 1988; 110():101-3. PubMed ID: 3043583
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant immunotherapy by levamisole in resectable lung cancer: a control study.
    Van Houtte P; Bondue H; Rocmans P; Michel J; Wybran J; Dalesio O; Balikdjian D; Vanderhoeft P; Kenis Y
    Eur J Cancer (1965); 1980 Dec; 16(12):1597-601. PubMed ID: 7014227
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased breast-cancer recurrence rate after adjuvant therapy with levamisole. A preliminary report. Executive Committee of the Danish Breast Cancer Cooperative Group.
    Lancet; 1980 Oct; 2(8199):824-7. PubMed ID: 6107500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant levamisole in breast cancer.
    Lancet; 1980 Nov; 2(8204):1133-4. PubMed ID: 6107740
    [No Abstract]   [Full Text] [Related]  

  • 19. Levamisole treatment in ulcus cruris. A double-blind placebo-controlled study.
    Morias J; Peremans W; Campaert H; Mertens RL
    Arzneimittelforschung; 1979; 29(7):1050-2. PubMed ID: 387047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.
    Spitler LE
    J Clin Oncol; 1991 May; 9(5):736-40. PubMed ID: 2016616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.